Dr Agarwal's Hea

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE943P01029
  • NSEID: AGARWALEYE
  • BSEID: 544350
INR
450.90
-5.95 (-1.3%)
BSENSE

Feb 06

BSE+NSE Vol: 52.79 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039533,
    "name": "Dr Agarwal's Hea",
    "stock_name": "Dr Agarwal's Hea",
    "full_name": "Dr Agarwals Health Care Ltd",
    "name_url": "stocks-analysis/dr-agarwal-s-hea",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "450.90",
    "chg": -5.95,
    "chgp": "-1.3%",
    "dir": -1,
    "prev_price": "456.85",
    "mcapval": "14,198.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544350,
    "symbol": "AGARWALEYE",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE943P01029",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "52.79 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-agarwal-s-hea-10039533-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Dr Agarwals Health Care Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-dr-agarwals-health-care-ltd-3810306",
        "imagepath": "",
        "date": "2026-01-29 23:16:54",
        "description": "The next results date for Dr Agarwals Health Care Ltd is scheduled for February 3, 2026...."
      },
      {
        "title": "Why is Dr Agarwal's Hea falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-agarwals-hea-fallingrising-3736316",
        "imagepath": "",
        "date": "2025-11-29 01:11:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Consistent Gains Outperforming Market Benchmarks</strong></p>\n<p>Over the past week, Dr Agarwals Health Care Ltd has delivered an impressive return of 7.77%, significantly outpacing the Sensex’s modest 0.56% gain during the same period. This strong relative performance highlights the stock’s resilience and appeal amid broader market fluctuations. Even on a monthly basis, the stock has appreciated by 2.78%, surpassing the Sensex’s 1.27% rise, signalling sustained momentum beyond short-term trading.</p>\n<p><strong>Technical Strength Evident in Moving Averages</strong></p>\n<p>The stock’s current price level is notably above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This technical positioning is a clear indicator of bullish sentiment among traders and investors, suggesting..."
      }
    ],
    "total": 96,
    "sid": "10039533",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-agarwals-health-care-10039533"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "04-Feb-2026",
      "details": "Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31 2025 at the analyst meet held on February 04 2026 is available on the website of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "03-Feb-2026",
      "details": "Presentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter and nine months ended December 31 2025 is attached.",
      "source": "BSE"
    },
    {
      "caption": "Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "03-Feb-2026",
      "details": "Consolidated and Standalone Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025 is attached.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

04-Feb-2026 | Source : BSE

Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31 2025 at the analyst meet held on February 04 2026 is available on the website of the Company.

Announcement under Regulation 30 (LODR)-Investor Presentation

03-Feb-2026 | Source : BSE

Presentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter and nine months ended December 31 2025 is attached.

Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.

03-Feb-2026 | Source : BSE

Consolidated and Standalone Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025 is attached.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available